Largest pharmaceutical companies by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Veradermics has the lowest figure of the 61 pharmaceutical companies ranked by total liabilities, at SGD 11.8M, followed by Belite Bio (SGD 13M) and Oruka Therapeutics (SGD 21.5M). Figures as of 18 Nov 2026, 18:28 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- VeradermicsSGD 11.8M
- Median
- SGD 2.7B
- Combined market value
- SGD 6.57T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | SGD 11.8M | SGD 6.8B | SGD 160.56 | 0.88% down | 233% up | ||
| 2 | Belite BioBLTE · Health Care | SGD 13M | SGD 8.2B | SGD 202.62 | 0.36% down | 31% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | SGD 21.5M | SGD 8.5B | SGD 124.66 | 0.38% up | 241% up | ||
| 4 | Edgewise TherapeuticsEWTX · Health Care | SGD 39.1M | SGD 5.9B | SGD 53.88 | 0.59% down | 88% up | ||
| 5 | Dianthus TherapeuticsDNTH · Health Care | SGD 48.4M | SGD 6.3B | SGD 112.58 | 0.39% up | 113% up | ||
| 6 | Protagonist TherapeuticsPTGX · Health Care | SGD 69M | SGD 10.6B | SGD 162.45 | 1.06% up | 46% up | ||
| 7 | Praxis Precision MedicinesPRAX · Health Care | SGD 77.1M | SGD 11.2B | SGD 399.03 | 1.45% up | 61% up | ||
| 8 | Spyre TherapeuticsSYRE · Health Care | SGD 80.6M | SGD 11.8B | SGD 124.68 | 3.08% up | 286% up | ||
| 9 | ErascaERAS · Health Care | SGD 91.5M | SGD 6B | SGD 17.24 | 3.74% down | 403% up | ||
| 10 | Summit TherapeuticsSMMT · Health Care | SGD 119M | SGD 10.9B | SGD 13.61 | 1.08% down | 36% down | ||
| 11 | Definium TherapeuticsDFTX · Health Care | SGD 139M | SGD 5.1B | SGD 37.35 | 1.40% down | 169% up | ||
| 12 | ABIVAXABVX · Health Care | SGD 184.7M | SGD 9.4B | SGD 107.90 | 1.94% up | 27% down | ||
| 13 | Corcept TherapeuticsCORT · Health Care | SGD 243.5M | SGD 9.6B | SGD 88.17 | 2.40% down | 8% down | ||
| 14 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SGD 252.7M | SGD 9.7B | SGD 122.82 | 0.16% up | 126% up | ||
| 15 | Rhythm PharmaceuticalsRYTM · Health Care | SGD 271M | SGD 10.7B | SGD 154.13 | 2.51% up | 13% up | ||
| 16 | Cogent BiosciencesCOGT · Health Care | SGD 388.4M | SGD 6.3B | SGD 36.37 | 1.29% up | 20% down | ||
| 17 | TG TherapeuticsTGTX · Health Care | SGD 535.4M | SGD 12.9B | SGD 85.21 | 5.39% up | 107% up | ||
| 18 | Roivant SciencesROIV · Health Care | SGD 536.7M | SGD 36.1B | SGD 49.75 | 0.31% down | 90% up | ||
| 19 | Travere TherapeuticsTVTX · Health Care | SGD 632.2M | SGD 6.3B | SGD 66.13 | 0.37% up | 44% up | ||
| 20 | Mirum PharmaceuticalsMIRM · Health Care | SGD 680.9M | SGD 7.8B | SGD 119.11 | 0.47% up | 31% up | ||
| 21 | Ligand PharmaceuticalsLGND · Health Care | SGD 700.6M | SGD 7.7B | SGD 385.75 | 1.83% up | 43% up | ||
| 22 | Axsome TherapeuticsAXSM · Health Care | SGD 775.5M | SGD 9.1B | SGD 173.50 | 1.02% down | 7% down | ||
| 23 | Madrigal PharmaceuticalsMDGL · Health Care | SGD 847M | SGD 12.2B | SGD 525.99 | 3.32% down | 24% down | ||
| 24 | AlkermesALKS · Health Care | SGD 860.9M | SGD 10.2B | SGD 60.49 | 3.23% up | 58% up | ||
| 25 | Legend BiotechLEGN · Health Care | SGD 943.3M | SGD 4.1B | SGD 20.98 | 0.99% up | 42% down | ||
| 26 | United TherapeuticsUTHR · Health Care | SGD 1B | SGD 32B | SGD 751.86 | 0.16% down | 23% up | ||
| 27 | Arrowhead PharmaceuticalsARWR · Health Care | SGD 1.1B | SGD 7.9B | SGD 56.22 | 1.43% up | 10% up | ||
| 28 | BioMarin PharmaceuticalBMRN · Health Care | SGD 1.9B | SGD 15.1B | SGD 78.20 | 3.67% up | 11% up | ||
| 29 | InsmedINSM · Health Care | SGD 2B | SGD 34.1B | SGD 155.46 | 1.05% down | 40% down | ||
| 30 | Ascendis PharmaASND · Health Care | SGD 2.1B | SGD 23B | SGD 350.87 | 0.35% up | 28% up | ||
| 31 | CytokineticsCYTK · Health Care | SGD 2.7B | SGD 9.3B | SGD 66.54 | 0.09% down | 20% down | ||
| 32 | Dr. Reddy's LaboratoriesRDY · Health Care | SGD 2.7B | SGD 16.2B | SGD 19.39 | 1.68% up | 5% up | ||
| 33 | BridgeBio PharmaBBIO · Health Care | SGD 3.9B | SGD 19.6B | SGD 100.79 | 1.78% up | 17% up | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | SGD 3.9B | SGD 6B | SGD 35.82 | 3.06% up | 64% down | ||
| 35 | PTC TherapeuticsPTCT · Health Care | SGD 4B | SGD 6.5B | SGD 77.87 | 0.07% up | 20% down | ||
| 36 | Amneal PharmaceuticalsAMRX · Health Care | SGD 4.7B | SGD 9.9B | SGD 28.44 | 4.45% up | 83% up | ||
| 37 | BeOne MedicinesONC · Health Care | SGD 4.9B | SGD 59.7B | SGD 522.57 | 1.92% down | 17% up | ||
| 38 | Alnylam PharmaceuticalsALNY · Health Care | SGD 5.4B | SGD 26.1B | SGD 194.78 | 3.47% down | 66% down | ||
| 39 | Elanco Animal HealthELAN · Health Care | SGD 8.8B | SGD 17.3B | SGD 34.70 | 4.10% up | 20% up | ||
| 40 | Vertex PharmaceuticalsVRTX · Health Care | SGD 9B | SGD 175.8B | SGD 693.34 | 0.67% up | 27% up | ||
| 41 | GenmabGMAB · Health Care | SGD 9.1B | SGD 41B | SGD 66.48 | 0.77% down | 70% up | ||
| 42 | Jazz PharmaceuticalsJAZZ · Health Care | SGD 9.5B | SGD 20.4B | SGD 318.27 | 2.55% up | 37% up | ||
| 43 | Regeneron PharmaceuticalsREGN · Health Care | SGD 12B | SGD 126.6B | SGD 1,224.14 | 0.87% down | 36% up | ||
| 44 | Royalty PharmaRPRX · Health Care | SGD 12.8B | SGD 51.5B | SGD 89.59 | 1.17% up | 78% up | ||
| 45 | ZoetisZTS · Health Care | SGD 15.6B | SGD 44.6B | SGD 109.80 | 2.01% up | 29% down | ||
| 46 | GrifolsGRFS · Health Care | SGD 17.3B | SGD 7.4B | SGD 10.93 | 1.81% down | 1% up | ||
| 47 | ViatrisVTRS · Health Care | SGD 29B | SGD 30.5B | SGD 26.64 | 1.05% up | 96% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | SGD 42.3B | SGD 63.4B | SGD 54.29 | 1.20% down | 74% up | ||
| 49 | Abbott LaboratoriesABT · Health Care | SGD 43.8B | SGD 233.6B | SGD 134.86 | 0.11% down | 17% down | ||
| 50 | Takeda PharmaceuticalTAK · Health Care | SGD 65.3B | SGD 88.2B | SGD 27.62 | 1.02% down | 54% up | ||
| 51 | Novo NordiskNVO · Health Care | SGD 66.7B | SGD 225.2B | SGD 51.10 | 2.62% down | 17% down | ||
| 52 | GSKGSK · Health Care | SGD 77.3B | SGD 126.3B | SGD 62.99 | 0.78% down | 6% up | ||
| 53 | SanofiSNY · Health Care | SGD 78.8B | SGD 146.7B | SGD 61.09 | 0.32% down | 4% down | ||
| 54 | NovartisNVS · Health Care | SGD 83B | SGD 380B | SGD 201.20 | 1.94% down | 25% up | ||
| 55 | AstraZenecaAZN · Health Care | SGD 84.3B | SGD 359.6B | SGD 231.85 | 1.34% down | 2% up | ||
| 56 | Bristol-Myers SquibbBMY · Health Care | SGD 92.2B | SGD 158.7B | SGD 77.64 | 1.84% down | 34% up | ||
| 57 | Merck & CoMRK · Health Care | SGD 108.6B | SGD 440.9B | SGD 178.85 | 3.24% down | 51% up | ||
| 58 | Eli LillyLLY · Health Care | SGD 110.8B | SGD 1.6T | SGD 1,801.76 | 1.28% down | 35% up | ||
| 59 | Johnson & JohnsonJNJ · Health Care | SGD 151.7B | SGD 856.1B | SGD 355.61 | 1.04% down | 38% up | ||
| 60 | PfizerPFE · Health Care | SGD 156.5B | SGD 207.2B | SGD 36.35 | 0.98% down | 14% up | ||
| 61 | AbbVieABBV · Health Care | SGD 176.9B | SGD 656.8B | SGD 371.58 | 1.58% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2893 SGD).
Questions and answers
Which pharmaceutical companies have the lowest total liabilities?
Veradermics (SGD 11.8M), Belite Bio (SGD 13M) and Oruka Therapeutics (SGD 21.5M) have the lowest total liabilities of the 61 pharmaceutical companies ranked here as of 18 Nov 2026, 18:28 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by total liabilities have a combined market value of SGD 6.57T as of 18 Nov 2026, 18:28 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.